Medicus Pharma effects 50-for-1 share consolidation effective Oct. 12, 2026
MDCX•Medicus Pharma will consolidate its shares 50-for-1 effective Oct. 12, 2026, targeting a higher bid price to regain compliance with Nasdaq’s minimum bid requirement.
1. Consolidation details
Nasdaq trading on a consolidated basis is expected to begin at the open on Oct. 12 under ticker MDCX. The post-consolidation common shares will have a new CUSIP, 58471K301.
